Generic Name and Formulations:
Neisseria meningitidis recombinant lipidated factor H binding protein (fHBP) variants 120mcg of Group B (subfamily A + subfamily B); per 0.5mL; susp for IM inj; contains polysorbate 80.
Indications for TRUMENBA:
Adults and Children:
<10yrs: not established. Give by IM inj in deltoid muscle of upper arm. 10–25yrs: 0.5mL given as 3-dose series according to a 0-, 2-, and 6-month schedule.
Severe allergic reaction after a previous dose of Trumenba.
Have epinephrine inj available. Immunosuppressed. Elderly. Pregnancy (Cat.B). Nursing mothers.
Concomitant other vaccines: see full labeling.
Inj site pain, fatigue, headache, muscle pain, chills, fever.
Single-dose prefilled syringes—5, 10
Endocrinology Advisor Articles
- Update on Vitamin D and Calcium Supplements for Reducing Fracture Risk
- AAP Shares List of 5 Unnecessary Pediatric Tests and Procedures
- Lower Risk for SGLT2i-Associated Genitourinary Infection With DPP-4i
- Severe Hypoglycemia Associated With Increased Mortality Risk in T2D
- Efficacy of CGM in Preterm Infants of Mothers With Diabetes
- High Grip Strength Associated With Lower Risk for Diabetes-Related AEs
- Statin Use for CVD Prevention Increases Diabetes Risk in Overweight Patients
- Optimal Timing of Gastric Bypass and Cholecystectomy When Both Procedures Clinically Indicated
- Does Asthma Contribute to Infertility?
- Short-Term Probiotics Increase Weight Loss in Overweight, Obesity